Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 2000, p. 1296-1301, Vol. 44, No. 5
Division of AIDS, STD, and TB Laboratory
Research,1 and Scientific Resources
Program,2 National Center for Infectious
Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
30333, and Third Wave Technologies, Inc., Madison,
Wisconsin 537193
Received 20 August 1999/Returned for modification 21 December
1999/Accepted 10 February 2000
We evaluated a recently described linear signal amplification
method for sensitivity and specificity in detecting mutations associated with resistance to rifampin (RIF) and isoniazid (INH) in
Mycobacterium tuberculosis. The assay utilizes the
thermostable flap endonuclease Cleavase VIII, derived from
Archaeoglobus fulgidus, which cleaves a structure formed by
the hybridization of two overlapping oligonucleotide probes to a target
nucleic acid strand. This method, termed the Invader assay, can
discriminate single-base differences. Nine pairs of probes,
encompassing five mutations in rpoB and katG
that are associated with resistance to either RIF or INH, as well as
the corresponding wild-type (drug-susceptible) alleles, were tested
using amplified DNA. Fluorescent-labeled cleavage products, ranging
from 4 to 13 nucleotides in length, depending on the genotype of the
test sample, were separated by denaturing polyacrylamide (20 to 24%)
gel electrophoresis and then detected by scanning. All nine alleles
could be identified and differentiated on the basis of product size.
Multiple mutations at a specific rpoB nucleotide in target
PCR products could be identified, as could mutants that were present at
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evaluation of the Invader Assay, a Linear Signal
Amplification Method, for Identification of Mutations Associated with
Resistance to Rifampin and Isoniazid in Mycobacterium
tuberculosis
0.5% of the total population of target sequences. The Invader assay
is a sensitive screen for some mutations associated with
antituberculosis drug resistance in amplified gene regions.
*
Corresponding author. Mailing address:
Tuberculosis/Mycobacteriology Branch, Centers for Disease Control and
Prevention, Mail stop F-08, Atlanta, GA 30333. Phone: (404) 639-1280. Fax: (404) 639-1287. E-mail: rcc1{at}cdc.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»